http://www.nytimes.com/2010/03/16/business/16hand.html

This article is essentially a PR piece by Auxilium, and contains nothing but positive spin. Every time I see a price quoted for Xiaflex treatment, it's higher than the last - in this article they're saying $5400. And it's nice to know that a good chunk of that money would go straight to the Wegman family, who did nothing with the drug for 10 years despite taking in millions from investors.

Edited 03/16/10 20:57